Document Detail


The role of small airways in lung disease.
MedLine Citation:
PMID:  11862964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The small airways constitute one of the least understood areas of the lungs. They play a role in many lung diseases, and small airway pathology results in significant morbidity New approaches to their evaluation may provide insights into this major area of lung disease. Asthma is well recognized as a disease of both large and small airways. Physiological and pathological evidence, from techniques such as post-mortem tissue histological analysis, induced sputum and transbronchial biopsies, has reinforced the concept of the involvement of the entire bronchial tree n the inflammatory process in asthma, In addition to describing the airway pathology in asthma, th s review focuses on the pathogenesis and role of small airway obstruction n other diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), sarcoidosis and obliterative bronchiolitis (OB). COPD is characterized by the presence of airflow obstruction resulting from lesions in the small airways. In addition, features compatible with small airways disease are common in IPF, sarcoidosis and OB. Recent advances in pulmonary imaging, such as high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI) with hyperpolarized 3He, have allowed non-invasive reproducible measurements of structure-function relationships to be made for the small airways. These techniques have great potential for diagnosing changes in small airway function and for assessing responses to treatment. New insights into the contribution of small airways to a range of lung diseases may lead to the development of therapies targeted at this part of the bronchial anatomy.
Authors:
R J Shaw; R Djukanovic; D P Tashkin; A B Millar; R M du Bois; P A Orr
Related Documents :
15786604 - Diagnosis of chronic obstructive pulmonary disease and differentiation from asthma.
17684334 - Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease ...
17766634 - Nonpharmacological and pharmacological interventions to prevent or reduce airway remode...
18187064 - Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and tre...
10649834 - Tick-borne diseases.
10789274 - Undifferentiated dementia, alzheimer's disease and vascular dementia: age- and gender-r...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Respiratory medicine     Volume:  96     ISSN:  0954-6111     ISO Abbreviation:  Respir Med     Publication Date:  2002 Feb 
Date Detail:
Created Date:  2002-02-25     Completed Date:  2002-03-13     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  67-80     Citation Subset:  IM    
Affiliation:
NHLI, Imperial College, Hammersmith Hospital, London, UK. r.shaw@ic.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bronchi / pathology*
Bronchiolitis Obliterans / drug therapy,  pathology
Drug Delivery Systems
Glucocorticoids / therapeutic use
Humans
Lung Diseases / drug therapy,  pathology*
Magnetic Resonance Imaging
Pulmonary Disease, Chronic Obstructive / drug therapy,  pathology
Pulmonary Fibrosis / drug therapy,  pathology
Respiratory Function Tests
Sarcoidosis / drug therapy,  pathology
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Glucocorticoids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reducing the caesarean delivery risk in elective inductions of labour: a decision analysis.
Next Document:  The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decid...